MedTrace Logo

A Digital Flu Intervention for People With Cardiovascular Conditions

NCT04584645 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49138

Last updated 2022-06-21

Study results available
· View outcomes & findings →

Summary

A 6-month prospective, digital randomized controlled trial targeting approximately 49,000 individuals to evaluate the effectiveness of an influenza vaccination intervention during influenza season for people with cardiovascular conditions

Conditions

Interventions

OTHER

Targeted digital intervention

Messages that provide informational content on the influenza vaccine (sourced from the Centers for Disease Control and Prevention and the American Heart Association), specific information about influenza and cardiovascular disorders, and behavioral prompts (e.g., reminders) surrounding influenza vaccination behaviors.

Sponsors & Collaborators

  • Sanofi Pasteur, a Sanofi Company

    collaborator INDUSTRY

  • Evidation Health

    lead INDUSTRY

Principal Investigators

  • Nell Marshall, DrPh · Evidation Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-21
Primary Completion
2021-04-12
Completion
2021-04-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04584645 on ClinicalTrials.gov